December
Claris Lifesciences Limited to Sell Its Global Generic Injectables Business to Baxter for US$ 625 millionFinancial Update for the quarter and six months ended September 30, 2016
October
The Economic Times coverage of Claris in Great Manager Awards 2016September
Claris in 'India's 50 Most Promising Brands' Coffee Table BookAugust
Claris receives ANDA approval for Flumazenil Injection after PAI InspectionClaris’ update on the PAI US FDA inspection
Financial Update for the quarter ended June 30, 2016
July
Claris receives ANDA approval for Bupivacaine InjectionMr. Arjun Handa, Vice Chairman & MD, in The Economic Times 'Promising Entrepreneurs of India' List
Mr. Arjun Handa, Vice Chairman & MD, has been featured in The Economic Times 'Promising Entrepreneurs of India' list, and his profile has been published in a premium coffee table book in Jun 2016.
The Economic Times highlighted the achievements and path breaking initiatives of the selected entrepreneurs in the coffee table book, ‘The Economic Times Promising Entrepreneurs of India’ with the theme of ‘Leading Disruptive Change’.
Click to view the publishing
Claris in Fortune 'The Next 500' List
Claris receives ANDA approval for Tobramycin Injection
June
India Ratings Affirms Claris Lifesciences at 'IND A'/StableThe Times of India features Claris' substantial share of the USA in total revenues
May
Claris announces receipt of EIR from the US FDAFinancial Update for the quarter and year ended March 31, 2016
